202 related articles for article (PubMed ID: 9191171)
21. Molecular mimicry in liver disease.
Burroughs AK; Butler P; Sternberg MJ; Baum H
Nature; 1992 Jul; 358(6385):377-8. PubMed ID: 1641019
[No Abstract] [Full Text] [Related]
22. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
[TBL] [Abstract][Full Text] [Related]
23. Genetics of autoimmune diseases.
Winchester R
Curr Opin Immunol; 1989 Apr; 1(4):701-7. PubMed ID: 2679723
[No Abstract] [Full Text] [Related]
24. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.
Vaysburd M; Lock C; McDevitt H
J Exp Med; 1995 Sep; 182(3):897-902. PubMed ID: 7650494
[TBL] [Abstract][Full Text] [Related]
25. Could HLA-DRB1 be the protective locus in rheumatoid arthritis?
Zanelli E; Gonzalez-Gay MA; David CS
Immunol Today; 1995 Jun; 16(6):274-8. PubMed ID: 7544977
[TBL] [Abstract][Full Text] [Related]
26. Immunobiology of the human major histocompatibility complex: association of HLA antigens with disease.
Mittal KK
Acta Anthropogenet; 1984; 8(3-4):245-68. PubMed ID: 6400312
[No Abstract] [Full Text] [Related]
27. Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse.
Yamane K; Yamamoto K; Yoshikawa Y; Sasazuki T
Clin Exp Immunol; 1996 Jan; 103(1):141-8. PubMed ID: 8565273
[TBL] [Abstract][Full Text] [Related]
28. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
[TBL] [Abstract][Full Text] [Related]
29. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases.
Wucherpfennig KW; Strominger JL
J Exp Med; 1995 May; 181(5):1597-601. PubMed ID: 7722439
[No Abstract] [Full Text] [Related]
30. The human Ia system.
Winchester RJ; Kunkel HG
Adv Immunol; 1979; 28():221-92. PubMed ID: 94505
[No Abstract] [Full Text] [Related]
31. Molecular aspects of HLA class II and some autoimmune diseases.
Lepage V; Lamm LU; Charron D
Eur J Immunogenet; 1993 Jun; 20(3):153-64. PubMed ID: 8338813
[No Abstract] [Full Text] [Related]
32. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
33. HLA transgenic mice as models of human autoimmune diseases.
Das P; Abraham R; David C
Rev Immunogenet; 2000; 2(1):105-14. PubMed ID: 11324683
[TBL] [Abstract][Full Text] [Related]
34. Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin.
Griffin AC; Zhao W; Wegmann KW; Hickley WF
Am J Pathol; 1995 Sep; 147(3):845-57. PubMed ID: 7545875
[TBL] [Abstract][Full Text] [Related]
35. Antigen presenting cells and the immunogenetics of autoimmune diabetes in NOD mice.
Leiter EH; Serreze DV
Reg Immunol; 1992; 4(5):263-73. PubMed ID: 1290746
[TBL] [Abstract][Full Text] [Related]
36. Linkage of faulty major histocompatibility complex class I to autoimmune diabetes.
Faustman D; Li XP; Lin HY; Fu YE; Eisenbarth G; Avruch J; Guo J
Science; 1991 Dec; 254(5039):1756-61. PubMed ID: 1763324
[TBL] [Abstract][Full Text] [Related]
37. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
[TBL] [Abstract][Full Text] [Related]
38. Human T cell clones as diagnostic tools and potential therapeutic reagents.
Weyand C; Goronzy J; Fathman CG
Immunol Invest; 1986 Nov; 15(7):591-624. PubMed ID: 2433217
[No Abstract] [Full Text] [Related]
39. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
40. Understanding the interaction of genetics and cellular responses in nonobese diabetic mice.
Ridgway WM; Fathman CG
Curr Dir Autoimmun; 2001; 4():218-38. PubMed ID: 11569404
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
